Quick Answer
OS Therapies Inc reported Operating Income Loss of -$28.71 million for the year ending 2025.
- OS Therapies Inc showed a decrease of -321.3% in Operating Income Loss from 2024 to 2025.
- This data is from OS Therapies Inc's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), OS Therapies Inc's Operating Income Loss has declined by 561.0%.
- Historical annual values: Fiscal year 2025: -$28.71 million | Fiscal year 2024: -$6.81 million | Fiscal year 2023: -$4.34 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: